Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to the Annual General Meeting of Sensys Gatso Group AB

The shareholders of Sensys Gatso Group AB (publ) reg no 556215-4459, (the “Company”) are hereby invited to the Annual General Meeting on Wednesday 8 May 2024 at 10.00 (CET) at the Company at Vasavägen 3c in Jönköping.The Board of Directors has, in accordance with Chapter 7, Section 4a of the Swedish Companies Act and the articles of association of the Company, resolved that the shareholders shall also have the right to exercise their voting rights through postal voting ahead of the Meeting. Thus, shareholders may choose to exercise their vote at the Meeting through being present in person,

Genova Property Group’s Annual Report 2023

The Annual Report for 2023, Swedish version, is now available at Genova´s website, www.genova.se. An English version will be published later. For further information, please contact:CEO, Michael Moschewitz, mobile +46 (0)70-713 69 39, michael.moschewitz@genova.se CFO, Henrik Zetterström, mobile +46 (0)70-870 04 96, henrik.zetterstrom@genova.se This information is information that Nyfosa AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact persons set out above, on 27 March

Corem divests 19 properties in Jönköping, Huddinge and Linköping for SEK 768 million

In two separate deals, Corem has signed agreements for the sale of 19 properties at an underlying property value of SEK 768 million, which is in line with book value.   In Huddinge, the property Ellipsen 5 is sold and in Linköping the leaseholds to the properties Magneten 2 and Megafonen 4 are sold. The properties mainly contain areas for light industry and warehouses with a total lettable area of approximately 9,050 sq.m.   In Jönköping and Huskvarna, 16 properties are sold, with a total lettable area of approximately 60,000 sq.m., which mainly contains premises for warehouses

Ahlstrom publishes its sustainability report 2023

AHLSTROM OYJ, PRESS RELEASE, MARCH 27, 2024 at 13:00 EET Ahlstrom, a global leader in fiber-based specialty materials, has today released its Sustainability Report for 2023. In addition to exploring key sustainability trends in Ahlstrom’s environment, the report includes information on Ahlstrom’s ongoing transformation, progress on its innovation agenda, and the transition plan for climate change mitigation. The audit firm KPMG Oy Ab has provided a limited assurance on Ahlstrom’s twelve prioritized sustainability metrics within the areas of materiality presented in the Sustainability

Aptahem reports top line results from the FIH study with Apta-1

Aptahem AB (publ), a biotech company developing treatments for patients suffering from acute inflammatory diseases such as sepsis, today announces top line results from the First in Human (FIH) study. The aim of the study was to evaluate safety and tolerability with the company’s lead candidate Apta-1 which was performed as a dose escalating study in healthy volunteers.The unblinded data from the study shows that Apta-1 has been well tolerated in the given doses. No serious side effects were seen and all participants fulfilled the study. In the additional analyzes that were performed during

ASETEK - Notice of Annual General Meeting April 30, 2024

The Board of Directors of Asetek A/S hereby gives notice of the annual general meeting to be held on April 30th 2024 in Aalborg, Denmark. The notice convening the general meeting, the agenda, and the full text of all proposals can be downloaded from here . On the day of the notice of the general meeting there are 98,313,892 shares and 98,313,892 voting rights in Asetek A/S. The following documents will be submitted to the general meeting: · Annual Report 202 (

UPDATE: Qlife is emphasizing its strategy to finalize regulatory and Go-To-Market in China, register in Asian countries through partners, and then file for approval in the UK and EU

It has been mentioned in the media that Qlife is no longer focused on the EU and other markets. However, as communicated previously, Qlife is focused on finalizing regulatory work in China and roll-out in China together with partner Hipro Biotechnology. Following this, the plan is to register in other Asian countries where partnerships have been established, as well as in the UK and EU. “As a small MedTech company, we must have an opportunistic view on where we can get our products to market first – the new regulatory framework in the EU has made it extremely resource-demanding to

Notice to convene Annual General Meeting in Wirtek A/S

Company Announcement no. 4/202427 March 2024   Wirtek A/S (CVR-nr. 26042232) convenes the Annual General Meeting to be held completely electronically on Wednesday, 17 April 2024 at 15:00 (CET). Agenda according to articles of association: 1. The board of directors' report on the activities of the company during the past financial year 2. Adoption of the annual report 3. Resolution on distribution of profit or loss recorded in the annual report adopted by the general meeting 4. Resolution on discharge of the board of directors and executive board 5. Appointment of

AMENDMENT: Notice of the Annual General Meeting in Wihlborgs Fastigheter AB (publ)

The correction refers to the date when shareholders who wish to participate in the Annual General Meeting physically or by postal voting must be entered in the register of shareholders maintained by Euroclear Sweden AB. This date is adjusted from April 18, as stated in the previous press release, to April 16. It is still possible to register your participation in the meeting by April 18 at the latest. The shareholders of Wihlborgs Fastigheter AB (publ) are hereby invited to attend the Annual General Meeting at 4:00 p.m. on Wednesday, 24 April 2024, at Slagthuset, Jörgen Kocksgatan 7 A in

Billerud’s Annual and Sustainability Report 2023

Billerud publishes its Annual and Sustainability Report for 2023.The Annual and Sustainability Report for 2023 is from today available on the company’s website and is attached to this press release. On Billerud’s website, there is also a digital short version of the Annual and Sustainability Report, please see https://www.billerud.com/2023-in-briefFor further information, contact:Lena Schattauer, Director Investor Relations, +46 8 553 335 10, ir@billerud.comUlrika Wedberg, EVP Sustainability & Public Affairs, +46 8 553 336 43, sustainability@billerud.comThis information is

Resolutions of Konecranes Plc’s Annual General Meeting of shareholders

KONECRANES PLC STOCK EXCHANGE RELEASE MARCH 27, 2024 at 12:30 PM EET   Resolutions of Konecranes Plc’s Annual General Meeting of shareholders   The Annual General Meeting of Konecranes Plc ("Konecranes" or the "Company") was held today, Wednesday 27 March 2024 at 10.00 am EET at Hyvinkääsali (address: Kauppatori 1, FI-05800 Hyvinkää, Finland).   The meeting approved the Company's annual accounts for the fiscal year 2023, discharged the members of the Board of Directors and the CEO from liability, and approved all proposals made by the Board of Directors and its committees

Change of Certified Adviser

COMPANY ANNOUNCEMENT NO. 96LED iBond International A/S has entered into an agreement with HC Andersen Capital, an approved certified adviser by Nasdaq First North Growth Market Denmark. The reason for the change has been, among other things, that HC Andersen Capital is a Danish-based certified adviser and that LED iBond wants a greater focus on Danish investors and investor communities. Martin Løbel, CEO of LED iBond international comments:  We would like to thank Västra Hamnen for being our Certified Adviser for four years since the IPO on Nasdaq First North Growth Market in 2020.

The place to be for developing and testing new medicines and technologies

Gothenburg has a lot of knowledge and capabilities within life science. But where Sweden’s second city really stands out is its collaborative approach and capacity to get things done, explains Iris Öhrn, investment advisor for life science at Business Region Göteborg.For more than a decade she’s been spreading word of the good things happening here and supporting companies and investors who want to become part it.  Gothenburg has a lot going on. And the ecosystem is experiencing rapid growth. “We are very strong in a lot of important areas including advanced therapies, regenerative

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

Oslo, 27 March 2024: Reference is made to the stock exchange announcement by Circio Holding ASA (OSE:CRNA) (“CIRCIO” or the “Company“) on 21 March 2024, regarding the requested conversion of convertible bonds by Atlas Special Opportunities, LLC. The share capital increase has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s new share capital is NOK 4,865,976.00 divided into 8,109,960 shares, each with a nominal value of NOK 0.60.

Slättö announces investment from Ares Management

Slättö and Ares Management Real Estate Secondaries funds (“Ares”) have agreed to support the recapitalization of a market-leading light-industrial and logistics portfolio, which is managed by Slättö. The portfolio comprises 28 assets with value concentrated in the Stockholm and Helsinki metropolitan areas.“We are delighted to work with Ares as a transaction partner,” says Jonas Andersson, Deputy Managing Partner at Slättö. “This deal is another testament to Slättö’s ability to attract the most sophisticated capital to our funds and conviction segments, using our unique capabilities to build

SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D

SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States. SyntheticMR is proud to announce that its next-generation imaging solution, SyMRI 3D, has received FDA 510(k) clearance for clinical use in the United States. This milestone marks a significant advancement in quantitative MRI technology, offering unprecedented resolution and accuracy in brain imaging. "We are thrilled to receive 510(k) clearance for SyMRI 3D," says Ulrik Harrysson, CEO at

NIB finances renewable energy supply for green ammonia production in Lithuania

The Nordic Investment Bank (NIB) and UAB LT Energija have signed a EUR 100 million loan for a 264 MW wind farm in Pagėgiai, Lithuania. The European Union supports EUR 43.5 million of the loan under the NIB's InvestEU Framework Operation on Clean Energy Transition.The 21-year maturity loan will finance the construction of 40 wind turbines, as well as the associated civil and electrical infrastructure. The Pagėgiai wind farm will significantly increase energy generation capacity in Lithuania, which currently imports the majority of its power consumption. It will generate an estimated 602

Minutes from the Annual General Meeting in Cessatech A/S

Cessatech A/S, CVR no. 41293055 (“Cessatech” or the “Company”) held its Annual General Meeting on Wednesday 27 March 2023 at 09:00 (CET) at the Company's address Kanonbådsvej 2, 1437 København K.The agenda for the general meeting was as follows: 1. ELECTION OF CHAIRMAN OF THE MEETING 1. Mikkel Rostock-Jensen was elected chairman of the meeting. The chairman of the meeting ascertained that none of the shareholders objected to the legality of the annual general meeting and announced that the annual general meeting had been duly convened and was legal and competent in terms of all

Report from the extraordinary general meeting of Biokraft International AB (publ)

Stockholm, 27 March 2024Biokraft International AB (publ), reg.no 556528-4733, has today held an extraordinary general meeting, at which the following was resolved. The meeting was conducted with the possibility to participate through postal voting.   Resolutions to amend the Articles of Association The extraordinary general meeting resolved, in accordance with the Board of Directors' proposal, to amend the company’s Articles of Association, whereby the limits of the share capital are changed to a minimum of SEK 87,000,000 and a maximum of SEK 348,000,000 and the number of shares to

MyfirstApp Sweden: CEO Update on Vision and the Future of the Company

MyfirstApp Sweden offers a range of digital services, primarily consisting of digital applications tailored for children. The solutions are used by numerous preschools/schools where the apps are adapted with various developmental levels for learning and personal development. The apps go by different names and cover areas such as basic mathematics and cognitive abilities.In early March 2024, the company's CEO, Jesper Nord, was interviewed by Per Stolt from Dagens Börs, read the full interview here  (in Swedish). Today, the company

Notice to the annual general meeting of ADDvise Group AB (publ)

ADDvise Group AB (publ), reg. no. 556363–2115, hereby convenes the annual general meeting on 3 May 2024 at 10:00 CEST at Grev Turegatan 30 in Stockholm. Entrance and registration start at 09.30 CEST. NOTIFICATIONShareholders wishing to attend the annual general meeting must: i)          be registered in the share register kept by Euroclear Sweden AB on the record date 24 April 2024, or, if the shareholder has had his/her shares registered in the name of a nominee, request that the nominee registers the shares for voting purposes in such time that the registration is completed no

The Swedish Medical Products Agency approves subgroup analysis in NextCell's ProTrans-Young study

NextCell Pharma AB ("NextCell" or the "Company") today announces that the Swedish Medical Products Agency has approved an application to conduct a subgroup analysis of the treatment effect of ProTrans in 30 adolescents in the age group 12-21 years, treated in the ProTrans-Young study. Principal Investigator Professor Per-Ola Carlsson and his team treated the last patient in the age group in February 2024. The approval for the subgroup analysis by the Swedish Medical Products Agency means that the primary efficacy endpoint readout is available after 12 months. The primary efficacy endpoint is

Hamlet BioPharma arranges a new series of digital events

Hamlet BioPharma invites you to a series of events aiming to provide insights into the project portfolio’s strong development pipeline, the advanced technologies and the committed and highly competent group of individuals that moves the company forward.   These events will be held on Zoom and open to the public, reflecting the company's commitment to transparency and engagement with the community. The first three presentations are scheduled for April 9th, May 8th, and June 12th.   The presentations represent an opportunity for participants to gain insights into our drug

There are no items matching the current filter
There are no more items matching the current filter
Back to top